Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome

Author: Cataldo Nicholas A.   Abbasi Fahim   McLaughlin Tracey L.   Basina Marina   Fechner Patricia Y.   Giudice Linda C.   Reaven Gerald M.  

Publisher: Oxford University Press

ISSN: 1460-2350

Source: Human Reproduction, Vol.21, Iss.1, 2006-01, pp. : 109-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content